{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T11:23:43Z","timestamp":1777548223266,"version":"3.51.4"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,28]]},"DOI":"10.7759\/cureus.107895","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:43:41Z","timestamp":1777398221000},"source":"Crossref","is-referenced-by-count":0,"title":["First Case of Deficiency of Adenosine Deaminase 2 (DADA2) in Oman With a Novel Mutation: A Case Report"],"prefix":"10.7759","author":[{"given":"Nasra M","family":"Al Ramadhani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruqaiya","family":"Al Jashmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safiya","family":"Al-Abrawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-018-0525-8","article-title":"Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment","volume":"38","author":"Meyts I","year":"2018","unstructured":"Meyts I, Aksentijevich I. Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment. J Clin Immunol. 2018, 38:569-78. 10.1007\/s10875-018-0525-8","journal-title":"J Clin Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-016-0111-7","article-title":"Monogenic polyarteritis: the lesson of ADA2 deficiency","volume":"14","author":"Caorsi R","year":"2016","unstructured":"Caorsi R, Penco F, Schena F, Gattorno M. Monogenic polyarteritis: the lesson of ADA2 deficiency. Pediatr Rheumatol Online J. 2016, 14:51. 10.1186\/s12969-016-0111-7","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.15894","article-title":"Evaluation and management of deficiency of adenosine deaminase 2: an international consensus statement","volume":"6","author":"Lee PY","year":"2023","unstructured":"Lee PY, Davidson BA, Abraham RS, et al.. Evaluation and management of deficiency of adenosine deaminase 2: an international consensus statement. JAMA Netw Open. 2023, 6:e2315894. 10.1001\/jamanetworkopen.2023.15894","journal-title":"JAMA Netw Open"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.12.908","article-title":"Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2)","volume":"145","author":"Lee PY","year":"2020","unstructured":"Lee PY, Kellner ES, Huang Y, et al.. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2). J Allergy Clin Immunol. 2020, 145:1664-1672.e10. 10.1016\/j.jaci.2019.12.908","journal-title":"J Allergy Clin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou Q","year":"2014","unstructured":"Zhou Q, Yang D, Ombrello AK, et al.. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014, 370:911-20. 10.1056\/NEJMoa1307361","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05711-w","article-title":"Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment","volume":"40","author":"Pinto B","year":"2021","unstructured":"Pinto B, Deo P, Sharma S, Syal A, Sharma A. Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment. Clin Rheumatol. 2021, 40:3883-96. 10.1007\/s10067-021-05711-w","journal-title":"Clin Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa837","article-title":"Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2)","volume":"60","author":"Cooray S","year":"2021","unstructured":"Cooray S, Omyinmi E, Hong Y, et al.. Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2). Rheumatology (Oxford). 2021, 60:4373-8. 10.1093\/rheumatology\/keaa837","journal-title":"Rheumatology (Oxford)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01098-0","article-title":"Hematopoietic cell transplantation cures adenosine deaminase 2 deficiency: report on 30 patients","volume":"41","author":"Hashem H","year":"2021","unstructured":"Hashem H, Bucciol G, Ozen S, et al.. Hematopoietic cell transplantation cures adenosine deaminase 2 deficiency: report on 30 patients. J Clin Immunol. 2021, 41:1633-47. 10.1007\/s10875-021-01098-0","journal-title":"J Clin Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/440285-first-case-of-deficiency-of-adenosine-deaminase-2-dada2-in-oman-with-a-novel-mutation-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:43:42Z","timestamp":1777398222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/440285-first-case-of-deficiency-of-adenosine-deaminase-2-dada2-in-oman-with-a-novel-mutation-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.107895","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,28]]}}}